<ul><li>Emcure Pharmaceuticals Ltd.'s subsidiary, Emcutix Biopharmaceuticals Ltd, has signed a partnership agreement with Italian company WiQo to sell 'PRX-PLUS,' a product used for skin tightening, in India.</li><li>The partnership grants Emcutix rights to import, distribute, and sell WiQo's 'PRX-PLUS' in India, providing a non-invasive and pain-free alternative to traditional aesthetic treatments.</li><li>Shares of Emcure Pharmaceuticals rose nearly 2% on the BSE following the announcement.</li><li>The dermatology market in India is experiencing significant growth, with the market size of the dermatology segment expected to reach approximately $1.8 billion.</li></ul>

Emcure Pharma Arm Ties Up With Italy’s WiQo To Sell Skin Tightening Product In India; Shares Rise

Discover more